Page last updated: 2024-08-18

pyrroles and Antidiuretic Hormone, Inappropriate Secretion

pyrroles has been researched along with Antidiuretic Hormone, Inappropriate Secretion in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.67)	18.2507
2000's	11 (73.33)	29.6817
2010's	3 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kilonzo, K; Lee, JJ; Nistico, A; Yeates, K	1
Laczi, F	1
Goldsmith, SR	1
Villabona, C	1
Er, F; Fuhr, U; Gassanov, N; Nia, AM; Semmo, M; Semmo, N	1
Blei, AT; Blendis, LM; Thuluvath, PJ; Wong, F	1
Ferguson, JW; Hayes, PC; Newby, DE; Therapondos, G	1
Gross, P; Herbrig, K; Palm, C; Pistrosch, F	1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P	1
Albright, JD; Bailey, T; Cervoni, P; Chan, PS; Coupet, J; Dusza, JP; Hartupee, D; Lai, F; Lock, TY; Mazandarani, H; Ning, X; Ochalski, L; Park, HC; Ru, X; Shepherd, C; Spinelli, W; Tanikella, T; Taylor, JR	1
Ezure, Y; Hasegawa, H; Koike, K; Kurasawa, T; Matsukawa, H; Naito, A; Ohtake, Y; Shigenobu, K; Tsuriya, Y	1
Arieff, AI	1
Decaux, G	2
Ezure, Y; Hasegawa, H; Koike, K; Kurasawa, T; Matsukawa, H; Naito, A; Ohtake, Y; Shigenobu, K	1

Reviews

10 review(s) available for pyrroles and Antidiuretic Hormone, Inappropriate Secretion

Article	Year
Management of hyponatremia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2014, May-13, Volume: 186, Issue:8 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Disease Management; Female; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Male; Morpholines; Prognosis; Pyrroles; Receptors, Vasopressin; Risk Assessment; Severity of Illness Index; Spiro Compounds; Tolvaptan; Treatment Outcome	2014
[Etiology, diagnostics and therapy of hyponatremias]. Orvosi hetilap, 2008, Jul-20, Volume: 149, Issue:29 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Blood Volume; Brain Diseases; Central Nervous System; Chronic Disease; Demeclocycline; Demyelinating Diseases; Diagnosis, Differential; Diuretics; Extracellular Fluid; Furosemide; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium Compounds; Morpholines; Osmolar Concentration; Osmosis; Pyrroles; Severity of Illness Index; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Vasopressins	2008
Treatment options for hyponatremia in heart failure. Heart failure reviews, 2009, Volume: 14, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pyrroles; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Treatment Outcome	2009
[Vasopressin receptor antagonists: the vaptans]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2 Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins	2010
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). European journal of clinical pharmacology, 2011, Volume: 67, Issue:4 Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Biological; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan; Water-Electrolyte Balance	2011
Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. Clinical science (London, England : 1979), 2003, Volume: 105, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Controlled Clinical Trials as Topic; Diuretics; Heart Failure; Homeostasis; Humans; Inappropriate ADH Syndrome; Liver Cirrhosis; Models, Animal; Morpholines; Piperidines; Pyrroles; Quinolones; Rats; Spiro Compounds; Vasopressins	2003
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. The American journal of medicine, 2006, Volume: 119, Issue:7 Suppl 1 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins	2006
Therapeutic potential of vasopressin receptor antagonists. Drugs, 2007, Volume: 67, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2007
VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist. Advances in experimental medicine and biology, 1998, Volume: 449 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Blood Pressure; Cyclic AMP; Dogs; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Pyrroles; Receptors, Vasopressin	1998
Treatment of hyponatremic encephalopathy with antagonists to antidiuretic hormone. The Journal of laboratory and clinical medicine, 2001, Volume: 138, Issue:1 Topics: Azepines; Benzamides; Brain Diseases, Metabolic; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Pyrroles; Vasopressins	2001

Trials

2 trial(s) available for pyrroles and Antidiuretic Hormone, Inappropriate Secretion

Article	Year
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1 Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance	2003
Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985. The Journal of laboratory and clinical medicine, 2001, Volume: 138, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Diuresis; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Potassium; Pyrroles; Sodium; Urea; Uric Acid; Water; Water-Electrolyte Balance	2001

Article

Year

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:1

Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Pyrroles; Renin; Sodium; Thirst; Treatment Outcome; Water-Electrolyte Balance

2003

Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.

The Journal of laboratory and clinical medicine, 2001, Volume: 138, Issue:1

Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Diuresis; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Osmolar Concentration; Potassium; Pyrroles; Sodium; Urea; Uric Acid; Water; Water-Electrolyte Balance

2001

Other Studies

3 other study(ies) available for pyrroles and Antidiuretic Hormone, Inappropriate Secretion

Article	Year
The therapeutic efficacy of VP-343, a selective vasopressin V2 receptor antagonist, in the experimental SIADH rat model. Biological & pharmaceutical bulletin, 2000, Volume: 23, Issue:11 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Deamino Arginine Vasopressin; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Renal Agents; Sodium; Urination; Urine	2000
Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V2 receptor antagonist. Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:8 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Deamino Arginine Vasopressin; Diuretics; Histocytochemistry; Inappropriate ADH Syndrome; Kidney; Male; Organ Size; Osmolar Concentration; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Renal Agents; Sodium; Urodynamics	2001
Treatment of hyponatremic encephalopathy. The Journal of laboratory and clinical medicine, 2001, Volume: 138, Issue:6 Topics: Azepines; Benzamides; Brain Diseases, Metabolic; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Pyrroles; Receptors, Vasopressin; Sodium Chloride	2001